For patients with severe mitral regurgitation, evidence of degenerative mitral valve disease on transesophageal echocardiography (TEE), and for those patients who are at high risk of surgical complications (based on the STS scoring system – see link), the Heart Valve Program at the AMITA Health Heart & Vascular Institute now offers an FDA-approved, minimally invasive procedure for mitral valve repair using the MitraClip® device.
